Table 3.

Frequency of Clinicians’ Management Decisions Regarding Medications by Vignette

Clinician responses (n = 334 total responses)	Vignette 1: HTN and diabetes mellitus	Vignette 2: HTN and renal disease	Vignette 3: HTN and coronary artery disease	Vignette 4: isolated systolic HTN
No changes in medications	n = 78	n = 30	n = 16	n = 46
	23.4% (19.8%, 28.8%)	9.0% (6.2%, 12.6%)	4.8% (2.8%, 7.7%)	13.8% (10.3%, 17.9%)
Increase dose of a current medication	n = 16	n = 9	n = 20	n = 106
	4.8% (3%, 8%)	2.7% (1.2%, 5.1%)	6.0% (3.7%, 9.1%)	31.7% (26.8%, 37.0%)
Discontinue a medication	n = 12	n = 56	n = 59	n = 16
	3.6% (2%, 6%)	16.8% (13.0%, 21.3%)	17.7% (13.7%, 22.2%)	4.8% (2.8%, 7.7%)
Add a new medication	n = 241	n = 287	n = 249	n = 172
	72.2% (67%, 77%)	86.2% (82.0%, 89.7%)	74.6% (69.5%, 79.1%)	51.5% (46.0%, 57.0%)

Percentages sum to greater than 100% because multiple treatment decisions were possible. Figures in parentheses are 95% confidence intervals

HTN = hypertension